Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-Avibactam
T. A. Alsenani, S. L. Viviani, Vijay Kumar, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 4
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo, et al.
Clinical Infectious Diseases (2023)
Open Access | Times Cited: 476
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
Pranita D. Tamma, Emily L. Heil, Julie Ann Justo, et al.
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 135
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview
Claire Amaris Hobson, Gautier Pierrat, Olivier Tenaillon, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 9
Open Access | Times Cited: 115
Klebsiella pneumoniae carbapenemase variants: the new threat to global public health
Li Ding, Siquan Shen, Jing Chen, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 4
Open Access | Times Cited: 65
Drug Discovery in the Field of β-Lactams: An Academic Perspective
Lian Jacobs, Patrick Consol, Yu Chen
Antibiotics (2024) Vol. 13, Iss. 1, pp. 59-59
Open Access | Times Cited: 13
The Structural Role of N170 in Substrate‐Assisted Deacylation in KPC‐2 β‐Lactamase
Diksha Parwana, Jing Gu, Shuang Chen, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Open Access | Times Cited: 9
Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae
Qingyu Shi, Siquan Shen, Chengkang Tang, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification
Eva Gato, Paula Guijarro-Sánchez, Isaac Alonso-García, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 4, pp. 106935-106935
Closed Access | Times Cited: 14
Cefepime–taniborbactam and ceftibuten–ledaborbactam maintain activity against KPC variants that lead to ceftazidime–avibactam resistance
Cullen L. Myers, Annie Stevenson, Brittany Miller, et al.
Antimicrobial Agents and Chemotherapy (2025) Vol. 69, Iss. 3
Open Access
Comparison of the in vitro activities and resistance mechanisms against imipenem–relebactam and ceftazidime–avibactam in clinical KPC-producing Klebsiella pneumoniae isolated in China
Yingyi Guo, Likang Yao, Jiong Wang, et al.
Infection (2025)
Open Access
The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate
André Birgy, Christina Nnabuife, Timothy Palzkill
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 3
Open Access | Times Cited: 4
Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae bla KPC-2 variants
J.-M. Zhang, Xu Jieli, Siquan Shen, et al.
Journal of Clinical Microbiology (2024) Vol. 62, Iss. 7
Open Access | Times Cited: 4
The primary pharmacology of ceftazidime/avibactam: resistancein vitro
Wright W. Nichols, Sushmita D. Lahiri, Patricia A. Bradford, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 3, pp. 569-585
Open Access | Times Cited: 7
Enhanced activity against a third-generation cephalosporin by destabilization of the active site of a class A beta-lactamase
Jing Sun, Aleksandra Chikunova, Aimee L. Boyle, et al.
International Journal of Biological Macromolecules (2023) Vol. 250, pp. 126160-126160
Open Access | Times Cited: 7
Capture ELISA for KPC Detection in Gram-Negative Bacilli: Development and Standardisation
André Valêncio, Miriam Aparecida da Silva, Fernanda Fernandes Santos, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1052-1052
Open Access | Times Cited: 5
Asp179 in the class A β‐lactamase from Mycobacterium tuberculosis is a conserved yet not essential residue due to epistasis
Ilona van Alen, Aleksandra Chikunova, Danny B. van Zanten, et al.
FEBS Journal (2023) Vol. 290, Iss. 20, pp. 4933-4949
Open Access | Times Cited: 5
Complex evolutionary trajectories in vivo of two novel KPC variants conferring ceftazidime-avibactam resistance
Chengkang Tang, Siquan Shen, Weiwei Yang, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 3, pp. 107265-107265
Closed Access | Times Cited: 1
The Effectiveness of Imipenem–Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-Lactamase
Krisztina M. Papp‐Wallace, Melissa D. Barnes, Magdalena A. Taracila, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 892-892
Open Access | Times Cited: 4
Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases
Miyanou Rosales‐Hurtado, Filomena Sannio, Lindita Lari, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 8, pp. 1546-1557
Open Access | Times Cited: 4
Exploring avibactam and relebactam inhibition of Klebsiella pneumoniae carbapenemase D179N variant: role of the Ω loop-held deacylation water
T. A. Alsenani, S. L. Viviani, Krisztina M. Papp‐Wallace, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 10
Open Access | Times Cited: 4
Klebsiella pneumoniae carbapenemase variant 44 acquires ceftazidime-avibactam resistance by altering the conformation of active-site loops
Zhizeng Sun, Hanfeng Lin, Liya Hu, et al.
Journal of Biological Chemistry (2023) Vol. 300, Iss. 1, pp. 105493-105493
Open Access | Times Cited: 4
Identification of Phytochemicals with Inhibitory Potential Against Beta-lactamase Enzymes via Computer-aided Approach
Goodness Chizorom Nwokebu, Abdurahman Babatunde Adesina, Clement Ndudi Isibor, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107238-107238
Closed Access | Times Cited: 1
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas -derived cephalosporinase
Andrew R. Mack, Vijay Kumar, Magdalena A. Taracila, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 11
Open Access | Times Cited: 3
Approaches to Testing Novel β-Lactam and β-Lactam Combination Agents in the Clinical Laboratory
Carmella Russo, Romney M. Humphries
Antibiotics (2023) Vol. 12, Iss. 12, pp. 1700-1700
Open Access | Times Cited: 2
The Structural Role of N170 in Substrate‐Assisted Deacylation in KPC‐2 β‐Lactamase
Diksha Parwana, Jing Gu, Shuang Chen, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 12
Open Access
Page 1 - Next Page

Scroll to top